Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes
. Nateglinide was developed by Ajinomoto, a Japanese company and sold by ...
Starlix® (nateglinide) is an oral antidiabetic agent used in the management of
Type 2 diabetes mellitus [also known as non-insulin dependent diabetes mellitus
Find patient medical information for nateglinide oral on WebMD including its uses
, side effects and safety, interactions, pictures, warnings and user ratings.
Nateglinide is an oral medication used to treat type 2 diabetes. Learn who it's for,
how it works, its side effects, warnings, and more.
Apr 17, 2015 ... Nateglinide (Starlix) is used to help lower blood sugar in people who have type 2
Jun 13, 2005 ... Nateglinide is an amino acid derivative that induces an early insulin response to
meals decreasing postprandial blood glucose levels. It should ...
Nateglinide - commercially known as Starlix - is a medication for diabetes
sufferers. Read more about nateglinide and starlix online at Patient.
AIMS: To compare the effect of adding nateglinide or placebo on postprandial
glucose excursions (PPGEs), glycated haemoglobin (HbA(1c)), diurnal glucose ...
Nateglinide is a short-acting, pancreatic, beta-cell-selective, K(ATP) potassium
channel blocker that improves overall glycemic control in type 2 diabetes.
Diabetes Care. 2000 Nov;23(11):1660-5. Nateglinide alone and in combination
with metformin improves glycemic control by reducing mealtime glucose levels ...